Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist...
16 insider purchases on record · latest filing 2022-08-12.
Insiders have also filed 117 sale transactions at ARTL.